Targeting arterial remodeling: a key tile in the mosaic of the therapeutic effects of relaxin in cardiovascular disease.

Suppr

超能文献

作者信息

Bani Daniele

出版信息

Hypertension. 2010 May;55(5):1095-6. doi: 10.1161/HYPERTENSIONAHA.110.152173. Epub 2010 Mar 29.

DOI:10.1161/HYPERTENSIONAHA.110.152173

PMID:20351339

Abstract

摘要

相似文献

Targeting arterial remodeling: a key tile in the mosaic of the therapeutic effects of relaxin in cardiovascular disease.

Hypertension. 2010 May;55(5):1095-6. doi: 10.1161/HYPERTENSIONAHA.110.152173. Epub 2010 Mar 29.

Relaxin therapy reverses large artery remodeling and improves arterial compliance in senescent spontaneously hypertensive rats.

Hypertension. 2010 May;55(5):1260-6. doi: 10.1161/HYPERTENSIONAHA.109.149369. Epub 2010 Mar 29.

Relaxin as a cardiovascular hormone: physiology, pathophysiology and therapeutic promises.

Cardiovasc Hematol Agents Med Chem. 2007 Apr;5(2):101-8. doi: 10.2174/187152507780363179.

Relaxin' the Heart: A Novel Therapeutic Modality.

J Cardiovasc Pharmacol Ther. 2016 Jul;21(4):353-62. doi: 10.1177/1074248415617851. Epub 2015 Nov 20.

Relaxin increases cardiac output and reduces systemic arterial load in hypertensive rats.

Hypertension. 2005 Oct;46(4):745-50. doi: 10.1161/01.HYP.0000184230.52059.33. Epub 2005 Sep 19.

Does serelaxin treatment alter passive mechanical wall properties in small resistance arteries?

Microcirculation. 2016 Nov;23(8):631-636. doi: 10.1111/micc.12321.

Recent Progress in the Therapeutic Role of Serelaxin in Vascular Dysfunction.

Curr Protein Pept Sci. 2018;19(11):1079-1087. doi: 10.2174/1389203719666180709103020.

'Relaxin' the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular disease.

Pharmacol Ther. 2006 Nov;112(2):529-52. doi: 10.1016/j.pharmthera.2005.05.012. Epub 2006 Jul 11.

Relaxin as a cardiovascular drug: a promise kept.

Curr Drug Saf. 2011 Nov 1;6(5):324-8. doi: 10.2174/157488611798918719.

Drugs of the future: the hormone relaxin.

Cell Mol Life Sci. 2007 Jun;64(12):1539-57. doi: 10.1007/s00018-007-6543-y.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Targeting arterial remodeling: a key tile in the mosaic of the therapeutic effects of relaxin in cardiovascular disease.

Hypertension. 2010 May;55(5):1095-6. doi: 10.1161/HYPERTENSIONAHA.110.152173. Epub 2010 Mar 29.

Relaxin therapy reverses large artery remodeling and improves arterial compliance in senescent spontaneously hypertensive rats.

Hypertension. 2010 May;55(5):1260-6. doi: 10.1161/HYPERTENSIONAHA.109.149369. Epub 2010 Mar 29.

Relaxin as a cardiovascular hormone: physiology, pathophysiology and therapeutic promises.

Cardiovasc Hematol Agents Med Chem. 2007 Apr;5(2):101-8. doi: 10.2174/187152507780363179.

Relaxin' the Heart: A Novel Therapeutic Modality.

J Cardiovasc Pharmacol Ther. 2016 Jul;21(4):353-62. doi: 10.1177/1074248415617851. Epub 2015 Nov 20.

Relaxin increases cardiac output and reduces systemic arterial load in hypertensive rats.

Hypertension. 2005 Oct;46(4):745-50. doi: 10.1161/01.HYP.0000184230.52059.33. Epub 2005 Sep 19.

Does serelaxin treatment alter passive mechanical wall properties in small resistance arteries?

Microcirculation. 2016 Nov;23(8):631-636. doi: 10.1111/micc.12321.

Recent Progress in the Therapeutic Role of Serelaxin in Vascular Dysfunction.

Curr Protein Pept Sci. 2018;19(11):1079-1087. doi: 10.2174/1389203719666180709103020.

'Relaxin' the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular disease.

Pharmacol Ther. 2006 Nov;112(2):529-52. doi: 10.1016/j.pharmthera.2005.05.012. Epub 2006 Jul 11.

Relaxin as a cardiovascular drug: a promise kept.

Curr Drug Saf. 2011 Nov 1;6(5):324-8. doi: 10.2174/157488611798918719.

Drugs of the future: the hormone relaxin.

Cell Mol Life Sci. 2007 Jun;64(12):1539-57. doi: 10.1007/s00018-007-6543-y.